The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Veit, Tiago Degani ^a   Chies, José Artur Bogo ^a   Switala, Magdalena ^b   Wagner, Bettina ^b   Horn, Peter A ^b   Busatto, Mauricio ^a   Brenol, Claiton Viegas ^c   Brenol, João Carlos Tavares ^c   Xavier, Ricardo Machado ^c   Rebmann, Vera ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; IMMUNOGLOBULIN RECEPTOR; METHOTREXATE; PROTEIN LILRB1; RHEUMATOID FACTOR; SOLUBLE HLA G ANTIGEN; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; PROTEIN BINDING;

ADULT; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; AGED; BLOOD; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; FEMALE; GENOTYPE; HLA-G ANTIGENS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC;

EID: 84928902459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123838     Document Type: Article

References (44)

1. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, et al. Identification of HLA-G7as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol. 2000; 61: 1138-49. PMID: 11137219
2. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 1994; 153: 5516-24. PMID: 7989753
3. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLAG mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A. 1994; 91: 4209-13. PMID: 8183892
4. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics. 2003; 55: 63-79. PMID: 12712263
5. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, et al. Identification of HLA-G7as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol. 2000; 61: 1138-49. PMID: 11137219
6. Carosella ED, Gregori S, LeMaoult J. The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood. 2011; 118: 6499-505. doi: 10.1182/blood-2011-07-370742 PMID: 21960588
7. Veit TD, Vianna P, Chies JAB. HLA-G-From Fetal Tolerance to a Regulatory Molecule in Inflammatory Diseases. Curr Immunol Rev. 2010; 6: 1-15.
8. Gonzalez A, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci. 2012; 49: 63-84. doi: 10.3109/ 10408363.2012.677947 PMID: 22537084
9. Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem. 2006; 281: 10439-47.PMID: 16455647
10. Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol. 2007; 37: 1924-37.PMID: 17549736
11. Zhong M, Weng X, Liang Z, Lu S, Li J, Chen X, et al. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse. Transplantation. 2009; 87: 8-15. doi: 10. 1097/TP.0b013e31818b6141 PMID: 19136885
12. Baricordi OR, Stignani M, Melchiorri L, Rizzo R. HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets. 2008; 7: 67-74. PMID: 18691135
13. Fainardi E, Castellazzi M, Stignani M, Morandi F, Sana G, Gonzalez R, et al. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci. 2011; 68: 433-51. doi: 10.1007/s00018-010-0584-3 PMID: 21080027
14. Khosrotehrani K, Le Danff C, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S. HLA-G expression in atopic dermatitis. J Invest Dermatol. 2001; 117: 750-2. PMID: 11564188
15. Wiendl H, Behrens L, Maier S, Johnson MA, Weiss EH, Hohlfeld R. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann Neurol. 2000; 48: 679-84. PMID: 11026456
16. Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, et al. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol. 2001; 159: 71-7. PMID: 11438456
17. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 2000; 101: 191-200. PMID: 11012772
18. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol. 2001; 22: 553-5. PMID: 11574278
19. Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, et al. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod. 2001; 7: 195-200. PMID: 11160846
20. Torres MI, Le Discorde M, Lorite P, Rios A, Gassull MA, Gil A, et al. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol. 2004; 16: 579-83. PMID: 15039388
21. Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, et al. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferonbeta in vitro and in vivo: rationale for the therapy of multiple sclerosis. J Neuroimmunol. 2005; 159: 155-64. PMID: 15652415
22. Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H. Soluble HLA-G in rheumatoidarthritis. Hum Immunol. 2006; 67: 561-7. PMID: 16916651
23. Rizzo R, Farina I, Bortolotti D, Galuppi E, Rotola A, Melchiorri L, et al. HLA-G may predict the disease course in patients with early rheumatoid arthritis. Hum Immunol. 2013.
24. Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M, et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics. 2006; 16: 615-23. PMID: 16906016
25. Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P. Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol. 1990; 17: 813-7. PMID: 2388204
26. Schutt P, Schutt B, Switala M, Bauer S, Stamatis G, Opalka B, et al. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol. 2010; 71: 489-95. doi: 10.1016/j.humimm.2010.02.015 PMID: 20156510
27. Rebmann V, Lemaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum Immunol. 2005; 66: 853-63. PMID: 16216668
28. Verloes A, Van de Velde H, LeMaoult J, Mateizel I, Cauffman G, Horn PA, et al. HLA-G expression in human embryonic stem cells and preimplantation embryos. J Immunol. 2011; 186: 2663-71. doi: 10. 4049/jimmunol.1001081 PMID: 21248264
29. Rebmann V, Switala M, Eue I, Schwahn E, Merzenich M, Grosse-Wilde H. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum Immunol. 2007; 68: 251-8. PMID: 17400060
30. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991; 19: 5444. PMID: 1681511
31. Hviid TV, Hylenius S, Hoegh aM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens. 2002; 60: 122-32. PMID: 12392506
32. Cordero EAA, Veit TD, Silva MAL, Jacques SMC, Silla LMDR, Chies JAB. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens. 2009: 308-13.doi: 10.1111/j.1399-0039.2009.01331.x PMID: 19775370
33. Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M, et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenetics and genomics. 2006; 16: 615-23. PMID: 16906016
34. Fainardi E, Rizzo R, Melchiorri L, Vaghi L, Castellazzi M, Marzola A, et al. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol. 2003; 142: 149-58. PMID: 14512174
35. Prigione I, Penco F, Martini A, Gattorno M, Pistoia V, Morandi F. HLA-G and HLA-E in patients with juvenile idiopathic arthritis. Rheumatology (Oxford). 2011; 50: 966-72. doi: 10.1093/rheumatology/ keq418 PMID: 21186170
36. Gonzalez A, Alegre E, Arroyo A, LeMaoult J, Echeveste JI. Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-like molecules in exudates. Clin Chem. 2011; 57: 1013-22. doi: 10.1373/clinchem.2010.159673 PMID: 21527645
37. Apps R, Sharkey A, Gardner L, Male V, Kennedy P, Masters L, et al. Ex vivo functional responses to HLA-G differ between blood and decidual NK cells. Molecular human reproduction. 2011; 17: 577-86.doi: 10.1093/molehr/gar022 PMID: 21471023
38. Zilberman S, Schenowitz C, Agaugue S, Benoit F, Riteau B, Rouzier R, et al. HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment. European journal of immunology. 2012; 42: 1599-608. doi: 10.1002/eji.201141761 PMID: 22678912
39. Kuroki K, Hirose K, Okabe Y, Fukunaga Y, Takahashi A, Shiroishi M, et al. The long-term immunosuppressive effects of disulfide-linked HLA-G dimer in mice with collagen-induced arthritis. Hum Immunol. 2013; 74: 433-8. doi: 10.1016/j.humimm.2012.11.060 PMID: 23276819
40. Naji A, Menier C, Maki G, Carosella ED, Rouas-Freiss N. Neoplastic B-cell growth is impaired by HLAG/ ILT2 interaction. Leukemia. 2012; 26: 1889-92. doi: 10.1038/leu.2012.62 PMID: 22441169
41. Rosado S, Perez-Chacon G, Mellor-Pita S, Sanchez-Vegazo I, Bellas-Menendez C, Citores MJ, et al. Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol. 2008; 69: 9-15. doi: 10.1016/j.humimm.2007.11.001 PMID: 18295670
42. Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens. 2008; 71: 520-9. doi: 10.1111/j.1399-0039.2008.01037.x PMID: 18380776
43. Rebmann V, van der Ven K, Pässler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue antigens. 2001; 57: 15-21. PMID: 11169254
44. Chen X-Y, Yan W-H, Lin a, Xu H-H, Zhang J-G, Wang X-X. The 14 bp deletion polymorphisms in HLAG gene play an important role in the expression of soluble HLA-G in plasma. Tissue antigens. 2008; 72: 335-41. doi: 10.1111/j.1399-0039.2008.01107.x PMID: 18700878